TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Levacetylleucine (Aqneursa) improved functioning in a phase III crossover trial of adults and children with ataxia-telangiectasia. Two patients had three treatment-emergent adverse events; none were ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
An electronics industry association report projected that the U.S. would surpass 100 million smart wearable users for the ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Morning Overview on MSN
A new pancreatic-cancer drug nearly doubled survival and cut the risk of death by 60%
Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared ...
HOUSTON, JULY 2, 2026 ― A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...
Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Many educators pursue careers in academia, hoping to engage and inspire the next generation. With iMotions Education, undergraduate lecturers have been able to increase enrollment and engagement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results